Published :
Tables : 43
Figures : 41
Category : Healthcare
No. of Pages : 215
Report Code : HC-1308
Hemorrhoid treatment devices market is poised to value USD 1016.15 million by 2028 end at a CAGR of 5.7% during the forecast period 2022 to 2028. Increasing cases of hemorrhoids are driving the growth of the market. According to the figures released by International Surgery Journal, hemorrhoids is one of the most common disorders among adults. The alarming rise of numbers has resulted in a growth of the surgery procedures, thus propelling the market. Rise in the geriatric population is also expected to spike the market growth. The affordability of non-invasive procedures is expected to fuel the growth of the market over the coming years. The market is bifurcated into by type, by usage area, and by region. On the basis of type, band ligators are expected to hold vast segment of the market. Band ligators are painless, ensures safety and have minimal complications, owing to these features there has been an increase in demand of the segment thus increasing the market share. Based on the usage area, hospitals are expected to show notable growth. Hospitals are the preferred destination of treatment owing to presence of better healthcare facilities and advanced technology. The tie-ups of hospitals with healthcare companies coupled with the rapid expansion of hospitals are accelerating the growth of the market. The increased funding for healthcare infrastructure alongside the presence of novel healthcare infrastructure in developed economies is positively influencing the growth of the market. In terms of region, North America is the front runner of the market. According to the figures released by the National Institute of Diabetes and Digestive Kidney Diseases, around 10.4 million Americans suffer from hemorrhoids and over 1 million new cases are reported every year. Out of these, only one in three individuals gets medical help and treatment. The rise in cases is expected to propel the market in the region. Rapid commercialization of novel products, presence of developed healthcare infrastructure and favorable reimbursement policies are also promoting the growth of the market in the region. Asia-Pacific region represents a lucrative opportunity for manufacturers owing to the increased government funding for healthcare infrastructure. The rising awareness of hemorrhoid treatment devices for hemorrhoid surgeries coupled with increasing adoption of advanced hemorrhoid treatment products is expected to boost the presence of the market in the region. Companies like Wuxi Shenkang Medical Instrument Equipment Co.Ltd and Zhengzhou Safute Electronic Equipment Co.,Ltd are actively present in the region. Key players of the market are : OBP Medical Corporation, Conmed Corporation, Privi Medical Pte. Ltd., Integra LifeSciences Corporation, Surkon Medical Co., Ltd., Boston Scientific Corporation, Cook Medical, Sklar Surgical Instruments and Johnson & Johnson. Competitive Landscape: Product launches are increasing the market size. De Scalene in 2019 launched a new device called Cryocure. The device is available at affordable rates and helps in stopping the bleeding from anal blood vessels PRIVI MEDICAL PTE. LTD. received clearance fro U.S FDA for its new device, Instalief Hemorrhoid Treatment Devices Market Segmentation : By Type Band Ligators Sclerotherapy Injections Cryotherapy Devices Infrared Coagulators Laser Probes Bipolar Probes Others By Usage Area Hospitals Clinics Ambulatory Surgery Centers By Region North America Europe Asia Pacific Latin America Middle East and Africa Hemorrhoid Treatment Devices Market Video Sample: FutureWise Key Takeaways: Growth Prospects SWOT Analysis Key Trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the market by type, by usage area and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) Evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the Middle East and Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financial and core competencies Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Increasing cases of hemorrhoids are driving the growth of the market. According to the figures released by International Surgery Journal, hemorrhoids is one of the most common disorders among adults. The alarming rise of numbers has resulted in a growth of the surgery procedures, thus propelling the market. Rise in the geriatric population is also expected to spike the market growth. The affordability of non-invasive procedures is expected to fuel the growth of the market over the coming years.
The market is bifurcated into by type, by usage area, and by region. On the basis of type, band ligators are expected to hold vast segment of the market. Band ligators are painless, ensures safety and have minimal complications, owing to these features there has been an increase in demand of the segment thus increasing the market share.
Based on the usage area, hospitals are expected to show notable growth. Hospitals are the preferred destination of treatment owing to presence of better healthcare facilities and advanced technology. The tie-ups of hospitals with healthcare companies coupled with the rapid expansion of hospitals are accelerating the growth of the market. The increased funding for healthcare infrastructure alongside the presence of novel healthcare infrastructure in developed economies is positively influencing the growth of the market.
In terms of region, North America is the front runner of the market. According to the figures released by the National Institute of Diabetes and Digestive Kidney Diseases, around 10.4 million Americans suffer from hemorrhoids and over 1 million new cases are reported every year. Out of these, only one in three individuals gets medical help and treatment. The rise in cases is expected to propel the market in the region. Rapid commercialization of novel products, presence of developed healthcare infrastructure and favorable reimbursement policies are also promoting the growth of the market in the region.
Asia-Pacific region represents a lucrative opportunity for manufacturers owing to the increased government funding for healthcare infrastructure. The rising awareness of hemorrhoid treatment devices for hemorrhoid surgeries coupled with increasing adoption of advanced hemorrhoid treatment products is expected to boost the presence of the market in the region. Companies like Wuxi Shenkang Medical Instrument Equipment Co.Ltd and Zhengzhou Safute Electronic Equipment Co.,Ltd are actively present in the region.
Key players of the market are : OBP Medical Corporation, Conmed Corporation, Privi Medical Pte. Ltd., Integra LifeSciences Corporation, Surkon Medical Co., Ltd., Boston Scientific Corporation, Cook Medical, Sklar Surgical Instruments and Johnson & Johnson.
Competitive Landscape:
Hemorrhoid Treatment Devices Market Segmentation :
By Type
By Usage Area
By Region
Hemorrhoid Treatment Devices Market Video Sample:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Hemorrhoid Treatment Devices Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Type Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Hemorrhoid Treatment Devices Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Hemorrhoid Treatment Devices Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Type Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Type Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Hemorrhoid Treatment Devices Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Band Ligators 7.2. Sclerotherapy Injections 7.3. Cryotherapy Devices 7.4. Infrared Coagulators 7.5. Laser Probes 7.6. Bipolar Probes 7.7. Others 8. Hemorrhoid Treatment Devices Market, By Usage Area Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Hospitals 8.2. Clinics 8.3. Ambulatory Surgery Centers 9. North America Hemorrhoid Treatment Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2022-2028 10. Latin America Hemorrhoid Treatment Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2022-2028 11. Europe Hemorrhoid Treatment Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2022-2028 12. Asia Pacific Hemorrhoid Treatment Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 13. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. GCC 13.2.2. Israel 13.2.3. South Africa 13.2.4. Rest of MEA 13.3. Market Size (USD Million) Forecast for MEA 2022-2028 14. Market Share Analysis and Competitive Landscape 14.1. Global Landscape - Key Players, Revenue and Presence 14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 14.3. Global Emerging Companies 14.4. North America - Market Share Analysis and Key Regional Players 14.5. Europe - Market Share Analysis and Key Regional Players 14.6. Asia Pacific - Market Share Analysis and Key Regional Players 14.7. Global Key Player - Growth Matrix 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 15.1. OBP Medical Corporation 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Conmed Corporation 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Privi Medical Pte. Ltd. 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Shaanxi Xingmao Industry Co., Ltd. 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5. Privi Medical Pte. Ltd. 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6. Integra LifeSciences Corporation 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Surkon Medical Co.Ltd. 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Boston Scientific Corporation 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Cook Medical 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10.Johnson & Johnson 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11.Sklar Surgical Instruments 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Hemorrhoid Treatment Devices Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Type Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Hemorrhoid Treatment Devices Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Hemorrhoid Treatment Devices Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Type Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Type Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Hemorrhoid Treatment Devices Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Band Ligators 7.2. Sclerotherapy Injections 7.3. Cryotherapy Devices 7.4. Infrared Coagulators 7.5. Laser Probes 7.6. Bipolar Probes 7.7. Others
8. Hemorrhoid Treatment Devices Market, By Usage Area Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Hospitals 8.2. Clinics 8.3. Ambulatory Surgery Centers
9. North America Hemorrhoid Treatment Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2022-2028
10. Latin America Hemorrhoid Treatment Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2022-2028
11. Europe Hemorrhoid Treatment Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2022-2028
12. Asia Pacific Hemorrhoid Treatment Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
13. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. GCC 13.2.2. Israel 13.2.3. South Africa 13.2.4. Rest of MEA 13.3. Market Size (USD Million) Forecast for MEA 2022-2028
14. Market Share Analysis and Competitive Landscape 14.1. Global Landscape - Key Players, Revenue and Presence 14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 14.3. Global Emerging Companies 14.4. North America - Market Share Analysis and Key Regional Players 14.5. Europe - Market Share Analysis and Key Regional Players 14.6. Asia Pacific - Market Share Analysis and Key Regional Players 14.7. Global Key Player - Growth Matrix
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 15.1. OBP Medical Corporation 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Conmed Corporation 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Privi Medical Pte. Ltd. 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Shaanxi Xingmao Industry Co., Ltd. 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5. Privi Medical Pte. Ltd. 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6. Integra LifeSciences Corporation 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Surkon Medical Co.Ltd. 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Boston Scientific Corporation 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Cook Medical 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10.Johnson & Johnson 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11.Sklar Surgical Instruments 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview
16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations
17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics